Article Listing - Generic OxyContin would be 'tragedy,' Ont. health minister says

FRESENIUS POST 53% INCREASE IN PROFITS

25 May 1992

German pharmaceutical and medical technology group, Fresenius, posted net profits of 15.9 million Deutschemarks ($9.6 million), up 53% in 1991....

HOECHST-ROUSSEL TO EXTEND LOPROX RANGE

25 May 1992

- Hoechst-Roussel is to develop additional products based on its antifungal agent Loprox (ciclo-pirox olamine). These will include a gel...

NEDOCROMIL IN GERMANY

25 May 1992

- Fisons' German subsidiary is to co-market the anti-asthmatic nedocromil sodium as Hamlamid with Asta Medica via its local subsidiary...

ARES-SERONO 1st QTR SALES UP 25%

25 May 1992

Swiss human fertility and pharmaceutical concern, Ares-Serono, made sales in the first quarter of 1992 of $198 million, up 15.5%...

SPARFLOXACIN DEAL

25 May 1992

ASTHMA DEATHS FALL

Asthma-related deaths in New Zealand have fallen sharply following a warning in 1989 that severe asthma patients should...

SMITHKLINE BEECHAM COMPETES GLOBALLY

25 May 1992

The scale and shape of SmithKline Beecham is no accident, Henry Wendt, company chairman, told shareholders at the annual general...

CORTECS SETS UP IN THE USA

25 May 1992

UK company Cortecs has opened its operations in New Jersey in the USA, it has announced. The US office will...

IFPMA DISCUSSES DRUG QUALITY AT WHA

25 May 1992

The 45th World Health Assembly in Geneva (see also page 15) has heard from Dick Arnold, executive vice president of...

JAPAN NHI PRICE CUTS AVERAGE 6.1%

25 May 1992

A study undertaken by the National Health Insurance Pricing Comm-ittee of the Federation of Pharm-ceutical Manufacturers Associations of Japan has...

GAMBRO PROFITS UP 25% FOR 1ST QUARTER

25 May 1992

Swedish medical equipment maker Gambro reported first-quarter 1992 pretax profits of 176 million Swed-ish kroner ($29.8 million), an increase of...